IGNE logo

Igene Biotechnology, Inc. Stock Price

OTCPK:IGNE Community·US$1.6k Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 0 Fair Values set on narratives written by author

IGNE Share Price Performance

US$0.000001
0.00 (0.00%)
US$0.000001
0.00 (0.00%)
Price US$0.000001

IGNE Community Narratives

There are no narratives available yet.

Snowflake Analysis

Low risk with weak fundamentals.

3 Risks
0 Rewards

Igene Biotechnology, Inc. Key Details

US$4.8k

Revenue

-US$36.0k

Cost of Revenue

US$40.8k

Gross Profit

US$2.4m

Other Expenses

-US$2.4m

Earnings

Last Reported Earnings
Sep 30, 2010
Next Reporting Earnings
n/a
0
0%
0%
0%
View Full Analysis

About IGNE

Founded
1981
Employees
n/a
CEO
Joseph Downs
WebsiteView website
www.igene.com

Igene Biotechnology, Inc. focuses on the research, development, production, and commercialization of specialty ingredients for human and animal nutrition. The company supplies natural astaxanthin, a nutrient used as a source of pigment for coloring farmed salmon and trout species. It also supplies ingredients and finished products to the nutraceutical and feed industry. The company also provides research and development services for microbial strain improvement and fermentation process development and scale up from shake flask, to pilot plant, to commercial sized fermentors; and analytical chemistry services for identification and quantization of carotenoids in foods, feeds, and animal tissues, including verification of wild versus farm raised salmonids. The company was formerly known as IGI Biotechnology, Inc. and changed its name to IGENE Biotechnology, Inc. in April 1986. IGENE Biotechnology, Inc. was founded in 1981 and is based in Columbia, Maryland.

Recent IGNE News & Updates

No updates

Recent updates

No updates